샘플 요청 목록

 카트 문의
시장보고서
상품코드
1551731

세계의 당뇨병성 안질환 장비 시장

Diabetic Eye Disease Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 270 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당뇨병성 안질환 장비(Diabetic Eye Disease Devices) 시장은 2030년까지 16억 달러에 도달

2023년에 10억 달러로 추정된 당뇨병성 안질환 장비 시장은 분석 기간 2023-2030년에 CAGR 6.2%로 성장하고 2030년에는 16억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 유리체 수술은 CAGR 6.4%로 추이하며 성장을 지속하여, 분석 기간이 끝날 때까지 12억 달러에 달할 것으로 예측됩니다. 레이저 수술 부문의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.

미국 시장은 2억 7,950만 달러로 추정, 중국은 CAGR 10.1%로 성장 예측

미국의 당뇨병성 안질환 장비 시장은 2023년 2억 7,950만 달러로 추정되었습니다. 세계 2위 경제대국인 중국은 2023-2030년 CAGR을 10.1%로 2030년까지 3억 3,750만 달러 규모에 이를 것으로 예측되고 있습니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.6%와 6.3%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.9%로 성장할 것으로 예측됩니다.

세계의 당뇨병성 안질환 장비 시장-주요 동향 및 촉진요인 요약

당뇨병성 안질환 장비란 무엇이며 왜 필요한가?

당뇨병성 안질환 장비는 당뇨병성 망막증, 당뇨병성 황반 부종, 백내장, 녹내장 등 당뇨병과 관련된 눈 상태를 진단, 모니터링, 치료하도록 설계된 특수 의료 도구 및 기술입니다. 이러한 질병은 신속하게 발견되고 관리되지 않으면 심각한 시력 장애와 실명을 초래할 수 있습니다. 당뇨병성 안질환 장비는 이러한 질병의 조기 발견과 지속적인 관리에 중요한 역할을 하고 있으며, 당뇨병성 안질환의 진행성을 감안할 때 이것은 매우 중요합니다. 당뇨병성 안질환 장비는 당뇨병 안경의 진행성을 고려할 때 매우 중요합니다. 이러한 장치의 중요성은 시력이 현저하게 떨어질 때까지 환자가 알지 못하는 미세 동맥류와 출혈과 같은 망막 장애의 초기 징후를 확인하는 능력에 있습니다. 적시에 개입을 가능하게 함으로써, 이들 기기는 당뇨병성 안질환의 예방이나 진행을 늦추는데 도움이 되어, 시력을 유지해 환자의 생활의 질을 향상시킵니다. 당뇨병 세계의 유병률이 계속 상승하고 있는 가운데, 효과적이고 신뢰성이 높은 당뇨병성 안질환 장비 수요는 당뇨병과 관련된 실명과의 싸움에서 그 어느 때보다도 중요해지고 있습니다.

기술 진보는 어떻게 당뇨병성 안질환 장비를 강화하는가?

기술 발전으로 당뇨병성 안질환 치료 장비의 효과와 정확성, 접근성이 크게 향상되었습니다. 빛간섭단층촬영(OCT) 및 안저 사진 촬영과 같은 최신 진단 도구는 망막의 고해상도 이미지를 제공하여 눈의 내부 구조를 자세히 검사할 수 있게 해줍니다. 이러한 기술은 임상의가 질병 진행을 나타낼 수 있는 망막의 미세한 변화를 식별할 수 있게 함으로써 당뇨병성 망막증과 황반부종의 조기 발견에 혁명을 일으켰습니다. 또한 이러한 기기에 인공지능(AI)과 머신러닝 알고리즘을 통합하여 진단 정확도와 효율성을 더욱 향상시켰습니다. AI 기반 망막 검사 도구는 당뇨병성 안질환의 징후가 있는지 이미지를 높은 정확도로 분석할 수 있으며, 종종 인간 전문가의 성능과 일치하거나 심지어 능가하는 경우도 있습니다. 이 기술은 안과 전문의의 접근이 제한될 수 있는 외딴 지역이나 의료 서비스가 취약한 지역에서 특히 유용합니다. 또한 망막 광응고술이나 국소 레이저 치료와 같은 레이저 치료 장비의 발전으로 치료의 정확성과 안전성이 향상되어 합병증의 위험이 줄어들고 환자 치료 결과가 개선되었습니다. 이러한 기술적 개선은 당뇨병성 안질환 치료 장비의 효과를 높일 뿐만 아니라 가용성과 사용성을 높여 더 많은 환자가 적시에 적절한 치료를 받을 수 있도록 돕습니다.

왜 환자와 건강 관리 제공업체는 당뇨병성 안질환 장비를 받아들이는가?

당뇨병성 안질환 장비 환자 및 건강 관리 제공업체의 채택이 증가하고 있는 배경은 당뇨병과 관련된 안 질환의 부담 증가를 관리하는 임박한 필요가 있습니다. 환자에게 이러한 장치는 눈 건강에 적극적인 접근을 제공하여 정기적 인 모니터링과 심각한 시력 저하로 이어지기 전에 잠재적인 문제를 조기에 발견 할 수 있습니다. 또한 망막 이미지와 OCT 스캔과 같은 비침습적인 진단 검사의 편의성으로 인해 환자는 불편함이나 장기간의 치료를 받지 않고 정기적인 검진을 받기 쉬워집니다. 게다가 당뇨병성 안질환과 관련된 위험에 대한 인식이 높아지고 첨단 스크리닝 기술을 이용할 수 있게 됨으로써 당뇨병 관리 계획의 일환으로 정기적인 안과 검진을 받는 환자가 증가하고 있습니다. 의료 서비스 제공업체에게 당뇨병성 안질환 장비는 당뇨병 환자의 눈 상태를 진단하고 진행을 추적할 수 있는 안정적이고 효율적인 수단을 제공합니다. 망막의 미묘한 변화를 조기에 발견하는 능력은 심각한 합병증을 예방하는 시기 적절한 개입을 가능하게 하여 궁극적으로 환자의 결과를 개선할 수 있습니다. 게다가 이러한 기기에 AI와 원격 의료 솔루션이 통합되어 특히 안과 서비스가 부족한 지역에서는 전문적인 치료에의 액세스가 확대되고, 이러한 기기는 현대의 당뇨병 관리에 필수적인 도구가 되었습니다.

당뇨병성 안질환 장비 시장 성장을 가속하는 요인은?

당뇨병성 안질환 장비 시장 성장은 당뇨병 세계의 유병률 증가와 합병증의 효과적인 관리의 필요성을 반영하는 몇 가지 중요한 요인에 의해 견인되고 있습니다. 주요 요인 중 하나는 세계의 당뇨병 이환율의 상승이며, 특히 고령화 사회와 비만률이 높고 앉아 쉽고 생활 습관이 많은 지역에서 두드러집니다. 당뇨병으로 진단받는 사람이 증가함에 따라 관련 눈 상태를 모니터링하고 치료할 수 있는 장비에 대한 수요가 급증하고 있습니다. 고해상도 이미징 시스템, 인공지능을 갖춘 진단 도구, 보다 정밀한 레이저 치료 개발 등 기술 발전도 시장 확대에 중요한 역할을 하고 있습니다. 이러한 기술 혁신은 당뇨병 안과 치료의 정확성, 안전성 및 접근성을 향상시켜 보다 조기 및 효과적인 진단 및 치료를 가능하게 했습니다. 또한 예방 헬스 케어와 조기 발견이 중시되어 스크리닝 프로그램에 대한 투자가 확대되어 일상 진료에 당뇨병성 안질환 장비가 채택되게 된 것도 시장 성장을 가속하는 큰 요인 되어 있습니다. 또한, 신흥 시장에서의 의료 인프라의 확대와 당뇨병에 의한 실명과 싸우는 정부의 이니셔티브이 이러한 장비 수요를 더욱 밀어 올리고 있습니다. 마지막으로, 정기적인 안과 검진의 중요성에 대한 환자들의 인식이 높아지고 첨단 진단 옵션이 제공되면서 당뇨병성 안질환 장비가 향후에도 당뇨병 치료의 중요한 구성 요소로 남을 수 있도록 시장의 지속적인 확장에 기여하고 있습니다.

조사 대상 기업 예(전 36건)

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International SA
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아 태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아 태평양
  • 남미
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 남미
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LYJ

Global Diabetic Eye Disease Devices Market to Reach US$1.6 Billion by 2030

The global market for Diabetic Eye Disease Devices estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Vitrectomy, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Laser Surgery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$279.5 Million While China is Forecast to Grow at 10.1% CAGR

The Diabetic Eye Disease Devices market in the U.S. is estimated at US$279.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$337.5 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Diabetic Eye Disease Devices Market - Key Trends and Drivers Summarized

What Are Diabetic Eye Disease Devices and Why Are They Essential?

Diabetic eye disease devices are specialized medical tools and technologies designed to diagnose, monitor, and treat eye conditions associated with diabetes, such as diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These conditions can lead to severe vision impairment or even blindness if not detected and managed promptly. Diabetic eye disease devices play a crucial role in the early detection and ongoing management of these conditions, which is vital given the progressive nature of diabetic eye diseases. The importance of these devices lies in their ability to identify early signs of retinal damage, such as microaneurysms or hemorrhages, that might not be noticeable to the patient until significant vision loss has occurred. By enabling timely interventions, these devices help prevent or slow the progression of diabetic eye diseases, thereby preserving vision and improving the quality of life for patients. As the global prevalence of diabetes continues to rise, the demand for effective and reliable diabetic eye disease devices has become more critical than ever in the fight against diabetes-related blindness.

How Are Technological Advances Enhancing Diabetic Eye Disease Devices?

Technological advancements have significantly enhanced the effectiveness, accuracy, and accessibility of diabetic eye disease devices. Modern diagnostic tools, such as optical coherence tomography (OCT) and fundus photography, provide high-resolution images of the retina, allowing for detailed examination of the eye's internal structures. These technologies have revolutionized the early detection of diabetic retinopathy and macular edema by enabling clinicians to identify minute changes in the retina that might indicate disease progression. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into these devices has further improved diagnostic accuracy and efficiency. AI-powered retinal screening tools can analyze images for signs of diabetic eye disease with a high degree of accuracy, often matching or even surpassing the performance of human experts. This technology is particularly valuable in remote or underserved areas, where access to ophthalmologists may be limited. Moreover, advancements in laser therapy devices, such as those used in panretinal photocoagulation or focal laser treatments, have improved the precision and safety of therapeutic interventions, reducing the risk of complications and enhancing patient outcomes. These technological improvements not only make diabetic eye disease devices more effective but also increase their availability and usability, helping more patients receive timely and appropriate care.

Why Are Patients and Healthcare Providers Embracing Diabetic Eye Disease Devices?

The growing adoption of diabetic eye disease devices by both patients and healthcare providers is driven by the pressing need to manage the rising burden of diabetes-related eye conditions. For patients, these devices offer a proactive approach to eye health, enabling regular monitoring and early detection of potential issues before they lead to significant vision loss. The convenience of non-invasive diagnostic tests, such as retinal imaging and OCT scans, also makes it easier for patients to undergo regular check-ups without discomfort or lengthy procedures. Additionally, the increasing awareness of the risks associated with diabetic eye disease, combined with the availability of advanced screening technologies, has encouraged more patients to seek regular eye care as part of their diabetes management plan. For healthcare providers, diabetic eye disease devices provide a reliable and efficient means of diagnosing and tracking the progression of eye conditions in diabetic patients. The ability to detect subtle retinal changes early on allows for timely interventions that can prevent severe complications, ultimately improving patient outcomes. Furthermore, the integration of AI and telemedicine solutions into these devices has expanded access to specialized care, particularly in regions where ophthalmology services are scarce, making these devices an indispensable tool in modern diabetes management.

What Factors Are Driving the Growth of the Diabetic Eye Disease Devices Market?

The growth in the diabetic eye disease devices market is driven by several key factors that reflect the increasing global prevalence of diabetes and the need for effective management of its complications. One of the primary drivers is the rising incidence of diabetes worldwide, particularly in aging populations and regions with high rates of obesity and sedentary lifestyles. As more people are diagnosed with diabetes, the demand for devices that can monitor and treat associated eye conditions has surged. Technological advancements, including the development of high-resolution imaging systems, AI-powered diagnostic tools, and more precise laser therapies, have also played a crucial role in expanding the market. These innovations have improved the accuracy, safety, and accessibility of diabetic eye care, making it possible to diagnose and treat conditions earlier and more effectively. Another significant factor driving market growth is the increasing emphasis on preventive healthcare and early detection, which has led to greater investment in screening programs and the adoption of diabetic eye disease devices in routine clinical practice. Additionally, the expansion of healthcare infrastructure in emerging markets, along with government initiatives to combat diabetes-related blindness, has further fueled the demand for these devices. Lastly, the growing awareness among patients about the importance of regular eye exams and the availability of advanced diagnostic options has contributed to the market's continued expansion, ensuring that diabetic eye disease devices will remain a critical component of diabetes care in the years to come.

Select Competitors (Total 36 Featured) -

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch + Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International S.A.
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Diabetic Eye Disease Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Expands Addressable Market Opportunity for Diabetic Eye Care
    • Advancements in Diagnostic Imaging Propel Growth in Diabetic Eye Disease Devices
    • Integration of AI and Machine Learning Strengthens the Business Case for Early Detection and Monitoring
    • Growing Focus on Preventive Healthcare Drives Adoption of Early Detection and Monitoring Tools
    • Innovations in Non-Invasive Testing Spur Growth in Diabetic Eye Disease Management
    • Increasing Awareness of Diabetic Retinopathy and Other Complications Generates Demand for Screening Devices
    • Expanding Healthcare Access Create New Growth Avenues for Diabetic Eye Disease Devices
    • Focus on Patient Compliance and User-Friendly Designs Sustains Growth in Home Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetic Eye Disease Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitrectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Laser Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ophthalmic Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제